(Q39893823)

15 September 2017

title

Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells (English)

1 reference

15 September 2017

11

1 reference

15 September 2017

C Boccaccio

10

0 references

author name string

M R Finkbeiner

1

1 reference

15 September 2017

A Astanehe

2

1 reference

15 September 2017

K To

3

1 reference

15 September 2017

A Fotovati

4

1 reference

15 September 2017

A H Davies

5

1 reference

15 September 2017

Y Zhao

6

1 reference

15 September 2017

H Jiang

7

1 reference

15 September 2017

A L Stratford

8

1 reference

15 September 2017

A Shadeo

9

1 reference

15 September 2017

P R Mertens

12

1 reference

15 September 2017

P Eirew

13

1 reference

15 September 2017

A Raouf

14

1 reference

15 September 2017

C J Eaves

15

1 reference

15 September 2017

S E Dunn

16

1 reference

15 September 2017

language of work or name

English

0 references

publication date

19 January 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

28

1 reference

15 September 2017

issue

11

1 reference

15 September 2017

page(s)

1421-1431

1 reference

Prospective identification of tumorigenic breast cancer cells

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Met, metastasis, motility and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Invasive growth: a MET-driven genetic programme for cancer and stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Gene expression profiling of breast cell lines identifies potential new basal markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Achievements in systemic therapies in the pregenomic era in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Drug development of MET inhibitors: targeting oncogene addiction and expedience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Hormonal interventions to prevent hormonal cancers: breast and prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

CD44 is required for two consecutive steps in HGF/c-Met signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Transcriptome analysis of the normal human mammary cell commitment and differentiation process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Essential role of Gab1 for signaling by the c-Met receptor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Comprehensive copy number profiles of breast cancer cell model genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Molecular definition of breast tumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Scatter-factor and semaphorin receptors: cell signalling for invasive growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

MET and MYC cooperate in mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

A modified polymerase chain reaction-long serial analysis of gene expression protocol identifies novel transcripts in human CD34+ bone marrow cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Tumor hypoxia and expression of c-met in cervical cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Purification and unique properties of mammary epithelial stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

Hepatocyte growth factor/Met system promotes endometrial and endometriotic stromal cell invasion via autocrine and paracrine pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.485

31 March 2020

Identifiers

DOI

10.1038/ONC.2008.485

1 reference

release_kuqnswgivfal5bi52apmpj7uki

15 September 2017

Fatcat ID

0 references

1 reference